Shanghai Bioprofile Snares ￥10M in Pre-A Round of Financing

Recently, proteome and metabolome technology service provider Shanghai Bioprofile ("Bioprofile") announced the completion of ￥10 million (US$1.4 million) Pre-A round of financing from Chinese venture firm Step Venture Capital. Phoenixtree Capital acts as the exclusive financial advisor. This fund is also the first financing event in the proteome field.

Proceeds of this financing will be used mainly for product research and development, team building and marketing, according to Hu Jianwen, the founder & CEO of Bioprofile.

Founded in 2017 by Dr. Haigui, Ph.D. from the Chinese Academy of Sciences, and senior specialists, Bioprofile is an innovative biotech firm. The founders have accumulated profound technology and experience in the field of proteome and metabolome. The founding team has more than 10 years of experience in proteomics, metabolome research and management, and participated in 3000 + technical service projects.

Bioprofile has invested a lot of manpower and material resources to provide the latest products and testing methods for precise medical treatment. It provides technical services in proteomics, metabolomics, genomics and transcriptomics, and is committed to promoting the application of proteomics, metabolomics and bioinformatics in scientific research at home and abroad.

Proteome is engaged in a high-throughput, high-sensitivity method for studying the types, expression levels, and modifications of proteins in cells, tissues, and body fluids. Proteome research objects involve humans, animal, plants, and microorganism, which can provide effective technical means for the screening of disease markers, the study of disease mechanism, plant resistance mechanism, and developmental mechanism. In the field of medicine, proteome gives strong support for precision medicine, drug target research, and efficacy analysis.

Step Venture Captial focuses on angel investment, including the early-stage venture investment of start-ups in the field of smart technology and Internet emerging services, to promote the development of entrepreneurship and angel investment industry.

Established in March 2014, Phoenixtree Capital is an investment bank jointly initiated by senior investment bankers and successful entrepreneurs in the industry. The company provides growth enterprises with equity financing, mergers and acquisitions and other services. Up to now, it has successfully helped over 100 enterprises complete financing with the total amount over billions of dollars.